Tumor cells often adopt mechanisms to hide their vulnerability by exploiting physiological immune checkpoints, such as those based on PD1/PD-L1 and CTLA4, to limit immune cell activation, and “metabolic checkpoints” (e.g., mTOR, PGC-1a), to win the competition for nutrients and metabolites. The gene discussed is CD274; the disease is neoplasm.